Ranibizumab treatment for retinal angiomatous proliferation lesions: a case report with life-long expectancy (seven years) follow-up
ContributorsDonati, Guy; Pournaras, Constantin
Published inKlinische Monatsblätter für Augenheilkunde, vol. 232, no. 4, p. 570-572
Publication date2015
Keywords
- Aged, 80 and over
- Angiogenesis Inhibitors/administration & dosage
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Life Expectancy
- Longitudinal Studies
- Ranibizumab/administration & dosage
- Retinal Neovascularization/diagnosis/drug therapy
- Treatment Outcome
- Vascular Endothelial Growth Factor A/antagonists & inhibitors
- Visual Acuity/drug effects
- Wet Macular Degeneration/diagnosis/drug therapy
Affiliation entities
Citation (ISO format)
DONATI, Guy, POURNARAS, Constantin. Ranibizumab treatment for retinal angiomatous proliferation lesions: a case report with life-long expectancy (seven years) follow-up. In: Klinische Monatsblätter für Augenheilkunde, 2015, vol. 232, n° 4, p. 570–572. doi: 10.1055/s-0034-1396332
Identifiers
- PID : unige:90490
- DOI : 10.1055/s-0034-1396332
- PMID : 25902126
Journal ISSN0023-2165
